4. Using a Risk Assessment Process to Determine Criticality of Product Quality Attributes

  1. Anurag S. Rathore2 and
  2. Rohin Mhatre3
  1. Mark A. Schenerman,
  2. Milton J. Axley,
  3. Cynthia N. Oliver,
  4. Kripa Ram and
  5. Gail F. Wasserman

Published Online: 28 OCT 2008

DOI: 10.1002/9780470466315.ch4

Quality by Design for Biopharmaceuticals: Principles and Case Studies

Quality by Design for Biopharmaceuticals: Principles and Case Studies

How to Cite

Schenerman, M. A., Axley, M. J., Oliver, C. N., Ram, K. and Wasserman, G. F. (2009) Using a Risk Assessment Process to Determine Criticality of Product Quality Attributes, in Quality by Design for Biopharmaceuticals: Principles and Case Studies (eds A. S. Rathore and R. Mhatre), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470466315.ch4

Editor Information

  1. 2

    Amgen Inc., Thousand Oaks, California, USA

  2. 3

    Biogen Idec, Cambridge, Massachusetts, USA

Author Information

  1. MedImmune, Gaithersburg, Maryland, USA

Publication History

  1. Published Online: 28 OCT 2008
  2. Published Print: 8 JUN 2009

ISBN Information

Print ISBN: 9780470282335

Online ISBN: 9780470466315

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Chapter for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >